ID
26113
Description
Study ID: 101468/219 Clinical Study ID: 101468/219 Study Title:An open label, randomised, five-way crossover single-dose pharmacokinetic study to assess dosage strength equivalence of ropinirole CR in healthy male and female volunteers Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 1 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: Requip Study Indication : Parkinson Disease Documentation part: Form D
Keywords
Versions (1)
- 10/9/17 10/9/17 -
Copyright Holder
GlaxoSmithKline
Uploaded on
October 9, 2017
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Dose strength equivalence of ropinirole CR in healthy adults Form D 101468/219
Form D Dose strength equivalence of ropinirole CR in healthy adults 101468/219
Similar models
Form D Dose strength equivalence of ropinirole CR in healthy adults 101468/219
C0011008 (UMLS CUI [1,2])
No comments